000047743 000__ 01240nam\a2200385\i\4500
000047743 001__ 47743
000047743 003__ SzGeWIPO
000047743 005__ 20240708150348.0
000047743 006__ m\\\\eo\\d\\\\\\\\
000047743 007__ cr bn |||m|||a
000047743 008__ 230320s2023\\\\ilu\\\\\o\\\\\000\0\eng\d
000047743 035__ $$a(OCoLC)1373643082
000047743 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047743 041__ $$aeng
000047743 24504 $$aThe United States Stands Alone :$$bA Divergence in the Treatment of Genus Claims in Pharmaceutical Patents, 22 UIC Rev. Intell. Prop. L. 97 (2022).
000047743 264_1 $$a[Chicago, Illinois] :$$bUIC Review of Intellectual Property Law,$$c2023
000047743 300__ $$a1 online resource (pages 97-111)
000047743 336__ $$atext$$2rdacontent
000047743 337__ $$acomputer$$2rdamedia
000047743 338__ $$aonline resource$$bcr$$2rdacarrier
000047743 4901_ $$aJohn Marshal Review of Intellectual Property Law,$$x1930-8140 ;$$vVolume 22, Issue 1, 2023, pages 97-111
000047743 542__ $$fhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1523&context=ripl
000047743 588__ $$aCrossref
000047743 590__ $$aPublished online: 2023
000047743 650_4 $$aPatent Law.
000047743 650_4 $$aDrugs$$xUnited States$$xPatents.
000047743 650_4 $$aPatent law and legislation$$xUnited States.
000047743 650_0 $$aPharmaceutical industry$$zUnited States.
000047743 7001_ $$aHabein, Sam,$$eauthor.
000047743 7730_ $$tJohn Marshal Review of Intellectual Property Law$$wJMR
000047743 830_0 $$aJohn Marshal Review of Intellectual Property Law ;$$vVolume 22, Issue 1, 2023, pages 97-111.
000047743 85641 $$uhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1523&context=ripl$$yonline version
000047743 904__ $$aJournal article
000047743 980__ $$aJMR